Meta‐analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis
暂无分享,去创建一个
[1] J. Gisbert,et al. Comparative effectiveness of azathioprine in Crohn’s disease and ulcerative colitis: prospective, long‐term, follow‐up study of 394 patients , 2008, Alimentary pharmacology & therapeutics.
[2] I. García,et al. Eficacia del mantenimiento con azatioprina sin ciclosporina oral tras un brote grave de colitis ulcerosa refractario a esteroides intravenosos , 2008 .
[3] M. Woodward,et al. How are Azathioprine and 6‐mercaptopurine dosed by gastroenterologists? Results of a survey of clinical practice , 2008, Inflammatory bowel diseases.
[4] S. Hutfless,et al. Mortality by medication use among patients with inflammatory bowel disease, 1996-2003. , 2007, Gastroenterology.
[5] M. A. Peris,et al. Optimización del tratamiento inmunomodulador con azatioprina o 6-mercaptopurina en pacientes con enfermedad inflamatoria intestinal , 2007 .
[6] A. Sood,et al. Long term results of use of azathioprine in patients with ulcerative colitis in India. , 2006, World journal of gastroenterology.
[7] J. Mate,et al. Systematic review: infliximab therapy in ulcerative colitis , 2006, Alimentary pharmacology & therapeutics.
[8] Sanjoy Banerjee,et al. Evolution of Thiopurine Use in Pediatric Inflammatory Bowel Disease in an Academic Center: Role of Thiopurine Methyltransferase and 6-Mercaptopurine Metabolite Measurements , 2006, Journal of pediatric gastroenterology and nutrition.
[9] T. Dassopoulos,et al. Steroid dependent ulcerative colitis: azathioprine use is finally "evidence-based". , 2006, Inflammatory bowel diseases.
[10] A. Bousvaros,et al. 5‐Aminosalicylate therapy is associated with higher 6‐thioguanine levels in adults and children with inflammatory bowel disease in remission on 6‐mercaptopurine or azathioprine , 2006, Inflammatory bowel diseases.
[11] B. Sands. Immunosuppressive drugs in ulcerative colitis: twisting facts to suit theories? , 2006, Gut.
[12] W. Tremaine,et al. American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. , 2006, Gastroenterology.
[13] S. Ghosh,et al. Is thiopurine therapy in ulcerative colitis as effective as in Crohn’s disease? , 2005, Gut.
[14] J. Glas,et al. The leukocyte count predicts the efficacy of treatment with azathioprine in inflammatory bowel disease. , 2005, European journal of medical research.
[15] G. Porro,et al. A rare cause of diuretic refractory ascites , 2005, Gut.
[16] P. Banks,et al. Are Patients with Inflammatory Bowel Disease Receiving Optimal Care? , 2005, The American Journal of Gastroenterology.
[17] V. Annese,et al. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[18] B. Bonaz,et al. 6‐Tioguanine monitoring in steroid‐dependent patients with inflammatory bowel diseases receiving azathioprine , 2005, Alimentary pharmacology & therapeutics.
[19] L. Griffel,et al. The Ten-year Single-center Experience With 6-Mercaptopurine in the Treatment of Inflammatory Bowel Disease , 2005, Journal of clinical gastroenterology.
[20] A. von Eckardstein,et al. Therapeutic drug monitoring of thiopurine drugs in patients with inflammatory bowel disease or autoimmune hepatitis , 2004, European journal of gastroenterology & hepatology.
[21] S. Hanauer,et al. The long‐term management of ulcerative colitis , 2004 .
[22] H. Ogata,et al. [A systematic review of the clinical effectiveness of azathioprine in patients with ulcerative colitis]. , 2004, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.
[23] D. Sanders,et al. Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease , 2004, Gut.
[24] A. López-Sanromán,et al. Efficacy and safety of thiopurinic immunomodulators (azathioprine and mercaptopurine) in steroid‐dependent ulcerative colitis , 2004, Alimentary pharmacology & therapeutics.
[25] K. Petraki,et al. A Prospective Randomized Observer-Blind 2-Year Trial of Azathioprine Monotherapy versus Azathioprine and Olsalazine for the Maintenance of Remission of Steroid-Dependent Ulcerative Colitis , 2004, American Journal of Gastroenterology.
[26] Richard E Thompson,et al. Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[27] P. Rutgeerts,et al. Long-term Outcome of Treatment with Intravenous Cyclosporin in Patients With Severe Ulcerative Colitis , 2004, Inflammatory bowel diseases.
[28] B. Korelitz,et al. A Search for the Optimal Duration of Treatment with 6-Mercaptopurine for Ulcerative Colitis , 2004, American Journal of Gastroenterology.
[29] M. Rizzetto,et al. [Need for hospital admission in patients with ulcerative colitis during maintenance with azathioprine]. , 2004, Minerva gastroenterologica e dietologica.
[30] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[31] H. Asakura. Role and side-effects of TPMT polymorphisms of 6-MP and azathioprine in the treatment of steroid-resistant and -dependent ulcerative colitis , 2003, Journal of Gastroenterology.
[32] T. Hibi,et al. Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis , 2003, Journal of Gastroenterology.
[33] K. Katsanos,et al. A report on efficacy and safety of azathioprine in a group of inflammatory bowel disease patients in northwest Greece. , 2003, Hepato-gastroenterology.
[34] M. Verhoef,et al. A national survey on the patterns of treatment of inflammatory bowel disease in Canada , 2003, BMC gastroenterology.
[35] A. Sood,et al. Azathioprine versus sulfasalazine in maintenance of remission in severe ulcerative colitis. , 2003, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.
[36] E. Cabré,et al. Azathioprine without oral ciclosporin in the long‐term maintenance of remission induced by intravenous ciclosporin in severe, steroid‐refractory ulcerative colitis , 2002, Alimentary pharmacology & therapeutics.
[37] O. Paoluzi,et al. Azathioprine or methotrexate in the treatment of patients with steroid‐dependent or steroid‐resistant ulcerative colitis: results of an open‐label study on efficacy and tolerability in inducing and maintaining remission , 2002, Alimentary pharmacology & therapeutics.
[38] K. Fellermann,et al. Response of Refractory Colitis to Intravenous or Oral Tacrolimus (FK506) , 2002, Inflammatory bowel diseases.
[39] O. Zmora,et al. Immunosuppressants and operation in ulcerative colitis1 , 2002 .
[40] M. A. Kamm,et al. Maintenance of remission in ulcerative colitis , 2002, Alimentary pharmacology & therapeutics.
[41] M. Kamm. Review article: maintenance of remission in ulcerative colitis. , 2002, Alimentary pharmacology & therapeutics.
[42] G. Actis,et al. An audit of the immunosuppressive management of ulcerative colitis. A retrospective chart review from a referral Day-Hospital of Gastro-enterology. , 2002, Minerva gastroenterologica e dietologica.
[43] D. Jewell,et al. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review , 2002, Gut.
[44] P. Beau,et al. [Compared azathioprine efficacy in ulcerative colitis and in Crohn's disease]. , 2002, Gastroenterologie clinique et biologique.
[45] T. Hibi,et al. Do immunosuppressants really work as maintenance therapy after the achievement of remission of severe ulcerative colitis? , 2002, Journal of Gastroenterology.
[46] A. Sood,et al. The beneficial effect of azathioprine on maintenance of remission in severe ulcerative colitis , 2002, Journal of Gastroenterology.
[47] R. Zinicola,et al. Immunosuppressants in distal ulcerative colitis , 2002 .
[48] C. Bernstein,et al. Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study , 2001, American Journal of Gastroenterology.
[49] S. Campbell,et al. Effective maintenance of inflammatory bowel disease remission by azathioprine does not require concurrent 5-aminosalicylate therapy , 2001, European journal of gastroenterology & hepatology.
[50] B. Vainer,et al. The treatment of inflammatory bowel disease with 6‐mercaptopurine or azathioprine , 2001, Alimentary pharmacology & therapeutics.
[51] S. Campbell,et al. Is neutropenia required for effective maintenance of remission during azathioprine therapy in inflammatory bowel disease? , 2001, European journal of gastroenterology & hepatology.
[52] G. Actis,et al. Safety and efficacy of azathioprine in the maintenance of ciclosporin‐induced remission of ulcerative colitis , 2001, Alimentary pharmacology & therapeutics.
[53] A. Zinsmeister,et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. , 2001, Gastroenterology.
[54] T. Bayless,et al. Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease , 2001, Gut.
[55] W. Sandborn,et al. Intravenous azathioprine in severe ulcerative colitis: a pilot study , 2000, American Journal of Gastroenterology.
[56] R. Moreno-otero,et al. 6‐Mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid‐dependent inflammatory bowel disease , 2000, European journal of gastroenterology & hepatology.
[57] Z H Khan,et al. Retrospective Case Series Analysis of Patients with Inflammatory Bowel Disease on Azathioprine , 2000, Digestion.
[58] M. Bala,et al. Annual cost of care for Crohn's disease: a payor perspective , 2000, American Journal of Gastroenterology.
[59] M. Neurath,et al. Mycophenolate mofetil versus azathioprine in patients with chronic active Ulcerative colitis : A 12-month pilot study , 2000 .
[60] B. Korelitz. A history of immunosuppressive drugs in the treatment of inflammatory bowel disease: origins at The Mount Sinai Hospital. , 2000, The Mount Sinai journal of medicine, New York.
[61] M. Neurath,et al. Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study , 2000, American Journal of Gastroenterology.
[62] J. Rask-Madsen,et al. IOIBD questionnaire on the clinical use of azathioprine, 6‐mercaptopurine, cyclosporin A and methotrexate in the treatment of inflammatory bowel diseases , 2000, European journal of gastroenterology & hepatology.
[63] Thomson,et al. Low‐dose intravenous azathioprine may be effective in the management of acute fulminant colitis complicating inflammatory bowel disease , 1999, Alimentary pharmacology & therapeutics.
[64] S. Hanauer,et al. Intravenous cyclosporin in ulcerative colitis: a five-year experience , 1999, American Journal of Gastroenterology.
[65] Williams,et al. Immunosuppressive therapy for ulcerative colitis: results of a nation‐wide survey among consultant physician members of the British Society of Gastroenterology , 1999, Alimentary pharmacology & therapeutics.
[66] G. Fick,et al. Azathioprine for maintaining remission of Crohn's disease. , 1998, The Cochrane database of systematic reviews.
[67] G. Porro,et al. Azathioprine in steroid-resistant and steroid-dependent ulcerative colitis. , 1997, Journal of clinical gastroenterology.
[68] E. Cabré,et al. Azathioprine is useful in maintaining long-term remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis. , 1996, The American journal of gastroenterology.
[69] Peppercom Ma. 6-mercaptopurine for the management of ulcerative colitis: a concept whose time has come. , 1996 .
[70] C. Bodian,et al. The long-term outcome of ulcerative colitis treated with 6-mercaptopurine. , 1996, The American journal of gastroenterology.
[71] A R Jadad,et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.
[72] P. Nos,et al. [Efficacy of 6-mercaptopurine in the treatment of inflammatory bowel disease]. , 1995, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.
[73] A. Axon,et al. Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. , 1992, BMJ.
[74] S. Ardizzone,et al. Azathioprine in the treatment of ulcerative colitis. , 1991, Journal of clinical gastroenterology.
[75] H. Winter,et al. Azathioprine in the treatment of children with inflammatory bowel disease. , 1990, The Journal of pediatrics.
[76] Adler Dj,et al. The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis. , 1990 .
[77] E. Prokipchuk,et al. Azathioprine therapy in chronic ulcerative colitis. , 1990, Journal of clinical gastroenterology.
[78] A. Axon,et al. The role of azathioprine in the management of ulcerative colitis , 1990, Diseases of the colon and rectum.
[79] J. Lennard-jones,et al. Controlled trial of azathioprine in chronic ulcerative colitis. , 1982, British medical journal.
[80] S. Mereu,et al. [Immunosuppressive therapy in ulcerative rectocolitis. Long-term assessment of results]. , 1982, Minerva medica.
[81] Y. Niv,et al. Imuran in the treatment of ulcerative colitis. , 1981, The American journal of gastroenterology.
[82] B. Levin,et al. A controlled trial of azathioprine in the management of chronic ulcerative colitis. , 1975, Gastroenterology.
[83] R. Caprilli,et al. A double-blind comparison of the effectiveness of azathioprine and sulfasalazine in idiopathic proctocolitis , 1975, The American Journal of Digestive Diseases.
[84] D. Jewell,et al. Azathioprine in Ulcerative Colitis: Final Report on Controlled Therapeutic Trial , 1974, British medical journal.
[85] K. Teleki,et al. [Immunosuppressive therapy of ulcerative colitis]. , 1972, Orvosi hetilap.
[86] J. Ra. Immunosuppressive therapy in ulcerative colitis. , 1969 .
[87] E. Theodor,et al. Treatment of Ulcerative Colitis with Azathioprine , 1968, British medical journal.
[88] M. Latorre Sánchez,et al. [Effectiveness of maintenance azathioprine therapy without oral cyclosporine after severe attacks of ulcerative colitis refractory to endovenous steroids]. , 2008, Gastroenterologia y hepatologia.
[89] A. Timmer,et al. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. , 2007, The Cochrane database of systematic reviews.
[90] P. Nos Mateu,et al. [Optimization of immunomodulatory treatment with azathioprine or 6-mercaptopurine in inflammatory bowel disease]. , 2007, Gastroenterologia y hepatologia.
[91] S. Hanauer. Review article: the long-term management of ulcerative colitis. , 2004, Alimentary pharmacology & therapeutics.
[92] J. Gisbert,et al. Preguntas y respuestas sobre el papel de la azatioprina y la 6-mercaptopurina en el tratamiento de la enfermedad inflamatoria intestinal , 2002 .
[93] J. Mate,et al. [Questions and answers on the role of azathioprine and 6-mercaptopurine in the treatment of inflammatory bowel disease]. , 2002, Gastroenterologia y hepatologia.
[94] A. Forbes,et al. Review article: Immunosuppressants in distal ulcerative colitis. , 2002, Alimentary pharmacology & therapeutics.
[95] O. Zmora,et al. Immunosuppressants and operation in ulcerative colitis. , 2002, Journal of the American College of Surgeons.
[96] G. Mantzaris,et al. Oral azathioprine for steroid refractory severe ulcerative colitis , 2001, American Journal of Gastroenterology.
[97] A. Sood,et al. Role of azathioprine in severe ulcerative colitis: one-year, placebo-controlled, randomized trial. , 2000, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.
[98] R. Modigliani,et al. Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease. , 2000, The Cochrane database of systematic reviews.
[99] R. Baldassano,et al. Experiences with 6-mercaptopurine and azathioprine therapy in pediatric patients with severe ulcerative colitis. , 1999, Journal of pediatric gastroenterology and nutrition.
[100] M. A. Peppercom. 6-mercaptopurine for the management of ulcerative colitis: a concept whose time has come. , 1996, The American journal of gastroenterology.
[101] J. Markowitz,et al. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum. , 1993, The American journal of gastroenterology.
[102] B. Korelitz,et al. The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis. , 1990, The American journal of gastroenterology.
[103] V. Drozdov,et al. [Effect of sulfasalizine with azathioprine on some immunologic indices in patients with nonspecific ulcerative colitis]. , 1970, Klinicheskaia meditsina.
[104] Rudnev Gp,et al. Glucocorticoid metabolism in the treatment of viral hepatitis , 1970 .